SpringWorks Therapeutics Stock (NASDAQ: SWTX) stock price, news, charts, stock research, profile.
Open | $43.930 |
Close | $42.470 |
Volume / Avg. | 807.284K / 1.105M |
Day Range | 42.420 - 44.350 |
52 Wk Range | 18.000 - 53.920 |
Market Cap | $3.162B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 17.43% |
Days to Cover | 12.76 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of SpringWorks Therapeutics (NASDAQ: SWTX) through any online brokerage.
Other companies in SpringWorks Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Alkermes (NASDAQ:ALKS).
The latest price target for SpringWorks Therapeutics (NASDAQ: SWTX) was reported by JP Morgan on Wednesday, March 6, 2024. The analyst firm set a price target for 75.00 expecting SWTX to rise to within 12 months (a possible 75.64% upside). 17 analyst firms have reported ratings in the last year.
The stock price for SpringWorks Therapeutics (NASDAQ: SWTX) is $42.7 last updated April 18, 2024 at 7:20 PM EDT.
There are no upcoming dividends for SpringWorks Therapeutics.
SpringWorks Therapeutics’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for SpringWorks Therapeutics.
SpringWorks Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.